CAPITAL INVESTMENT ADVISORY SERVICES, LLC CRISPR Therapeutics AG Transaction History

CAPITAL INVESTMENT ADVISORY SERVICES, LLC portfolio value:

$1.91M
portfolio value

CAPITAL INVESTMENT ADVISORY SERVICES, LLC quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +3.87% 1.09K shares 201K $65.35 29.32K
Q2 2022 share Increase +4.60% 1.24K shares 21K $60.77 28.22K
Q1 2022 share Increase +32.32% 6.59K shares 148K $62.77 26.98K
Q4 2021 share Decrease -7.64% -1.68K shares -926K $78.85 20.39K
Q3 2021 share Decrease -2.34% -529 shares -1.18M $111.93 22.08K
Q2 2021 share Increase +8.95% 1.85K shares 1.13M $161.89 22.61K
Q1 2021 share Increase +24.06% 4.02K shares -33K $121.85 20.75K
Q4 2020 share Decrease -24.17% -5.33K shares 717K $153.11 16.73K
Q3 2020 share Decrease -17.79% -4.77K shares -127K $83.64 22.06K
Q2 2020 share Increase +9.79% 2.39K shares 935K $73.49 26.83K
Q1 2020 share Increase +3.98% 935 shares -395K $42.41 24.44K
Q4 2019 share Decrease -0.28% -65 shares 466K $60.91 23.50K
Q3 2019 share Decrease -2.86% -695 shares -233K $40.99 23.57K
Q2 2019 share Increase +6.19% 1.41K shares 383K $47.1 24.26K
Q1 2019 share Decrease -9.59% -2.42K shares 94K $35.72 22.85K
Q4 2018 share Increase +49.55% 8.37K shares -28K $28.57 25.27K
Q3 2018 share Decrease -5.90% -1.06K shares -306K $44.35 16.90K
Q2 2018 share Increase +26.86% 3.80K shares 409K $58.76 17.96K
Q1 2018 share Increase +37.48% 3.86K shares 405K $45.71 14.16K
Q4 2017 share Decrease -4.63% -500 shares 49K $23.48 10.3K
Q3 2017 share Increase 0.00% 10.8K shares 193K $17.87 10.8K